Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoki Todo

Showing results (91-100 of 96) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 96 results.
Biochemical and Biophysical Research Communications|January 11, 2014
PCDH10 is required for the tumorigenicity of glioblastoma cellsKanae Echizen, Mitsutoshi Nakada, Tomoatsu Hayashi, et al.
Cell Reports|October 7, 2014
5-Hydroxymethylcytosine plays a critical role in glioblastomagenesis by recruiting the CHTOP-methylosome complexHiroki Takai, Koji Masuda, Tomohiro Sato, et al.
Oncogene|March 17, 2021
CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathwayKazuya Fukasawa, Takuya Kadota, Tetsuhiro Horie, et al.
Nature Communications|April 1, 2025
Lysine-arginine imbalance overcomes therapeutic tolerance governed by the transcription factor E3-lysosome axis in glioblastomaYongwei Jing, Masahiko Kobayashi, Mahmoud I Shoulkamy, et al.
Cancer Chemotherapy and Pharmacology|December 12, 2012
Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305)Soichiro Shibui, Yoshitaka Narita, Junki Mizusawa, et al.
The Lancet. Oncology|October 3, 2024
A brave new framework for glioma drug developmentKelly M Hotchkiss, Philipp Karschnia, Karisa C Schreck, et al.
Pageof 10

Showing results (91-100 of 96) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
Biochemical and Biophysical Research Communications|January 11, 2014
PCDH10 is required for the tumorigenicity of glioblastoma cellsKanae Echizen, Mitsutoshi Nakada, Tomoatsu Hayashi, et al.
Cell Reports|October 7, 2014
5-Hydroxymethylcytosine plays a critical role in glioblastomagenesis by recruiting the CHTOP-methylosome complexHiroki Takai, Koji Masuda, Tomohiro Sato, et al.
Oncogene|March 17, 2021
CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathwayKazuya Fukasawa, Takuya Kadota, Tetsuhiro Horie, et al.
Nature Communications|April 1, 2025
Lysine-arginine imbalance overcomes therapeutic tolerance governed by the transcription factor E3-lysosome axis in glioblastomaYongwei Jing, Masahiko Kobayashi, Mahmoud I Shoulkamy, et al.
Cancer Chemotherapy and Pharmacology|December 12, 2012
Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305)Soichiro Shibui, Yoshitaka Narita, Junki Mizusawa, et al.
The Lancet. Oncology|October 3, 2024
A brave new framework for glioma drug developmentKelly M Hotchkiss, Philipp Karschnia, Karisa C Schreck, et al.
Pageof 10